SINGAPORE: Doctors in Singapore are using remdesivir – a drug created originally to tackle Ebola – to treat COVID-19 patients here as part of clinical trials. Dr Shawn Vasoo, clinical director at the National Centre for Infectious Diseases (NCID), told CNA that there are "no proven therapies" for the coronavirus, and that remdesivir is among the drugs being trialled here as a possible treatment for COVID-19 patients. Antiviral drug remdesivir has been described by the World Health Organization as one of the most promising therapies against COVID-19, which also includes two HIV drugs and anti-malaria medications chloroquine and hydroxychloroquine. Remdesivir was granted emergency use authorisation by the US Food and Drug Administration (FDA) last Friday (May 1) for severe COVID-19 cases. Japan said a day later it would "fast-track" a review of the drug so that it can be approved for use within "a week of so". The NCID is part of a workgroup announced by Health Minister Gan Kim Yong in March that is looking at how repurposed drugs and new therapies can be used to treat the disease. READ: Singapore scientists plan to start testing COVID-19 vaccine this year These include antiviral drugs, anti-inflammatory drugs, humoral therapies such as convalescent plasma and… Read full this story
- MediciNova Announces Clinical Data from Subgroup Analyses of Completed Clinical Trial of MN-166 (ibudilast) in ALS
- OncBioMune’s Phase 2 Clinical Trial of ProscaVax for Early-Stage Prostate Cancer is Now Included on ClinicalTrials.gov
- More South Jersey cancer patients are participating in clinical trials
- Clinical trials expanding in cancer fight
- Why So Many Clinical Trials Attract So Few Participants and How That Hurts Us
- Atlantic Health chosen for clinical trials of pancreatic cancer meds
- The clinical trials near Leicestershire which pay thousands
- Years after promise of stem cells seemed to be fading, clinical trials underway
- Penn Medicine treats two cancer patients with gene-editing tool CRISPR
- Congo Ebola outbreak not an 'emergency of international concern,' WHO says
Ebola drug remdesivir used to treat COVID-19 patients in Singapore as part of clinical trials have 318 words, post on www.channelnewsasia.com at May 5, 2020. This is cached page on Vietnam Colors. If you want remove this page, please contact us.